Navigation Links
Takeda and Arbor Announce a Licensing Agreement for EDARBI and EDARBYCLOR
Date:9/12/2013

ilure of product development programs; (5) actions of regulatory authorities and the timing thereof; (6) changes in exchange rates; (7) claims or concerns regarding the safety or efficacy of marketed products or product candidates in development; and (8) integration activities with acquired companies.

The forward-looking statements contained in this press release speak only as of the date of this press release, and Takeda undertakes no obligation to revise or update any forward-looking statements to reflect new information, future events or circumstances after the date of the forward-looking statement. If Takeda does update or correct one or more of these statements, investors and others should not conclude that Takeda will make additional updates or corrections.

Contacts:
Takeda Pharmaceuticals U.S.A., Inc.
Kara Hoeger
+1-224-554-1277
kara.hoeger@takeda.com

Takeda Pharmaceutical Company Limited
Corporate Communications Dept. (PR/IR)
+81-3-3278-2083

Arbor Pharmaceuticals, LLC
Brian Adams
+1-404-496-5915
badams@arborpharma.com


'/>"/>
SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Takedas New Investigational Drug Vedolizumab is Granted Priority Review Status by U.S. Food and Drug Administration for Ulcerative Colitis
2. Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Car
3. Takeda and Zinfandel Pharmaceuticals Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimers Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm
4. Takeda Launches New Subsidiary in Peru
5. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
6. Among New Agents Entering the Unipolar Depression Market Over the Next Decade, Lundbeck/Takeda Pharmaceuticals Brintellix Has Blockbuster Potential
7. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
8. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
9. AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
10. Takeda to Acquire Inviragen, Inc.
11. Takeda Responds to Verdict in Diabetes Drug Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 Tianyin Pharmaceutical ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today updates the timeline ... Facility (QLF). The Company is ... dataset for China Food & Drug Administration,s (CFDA) ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- Academy Leadership, ... service academy graduates, has published a case study ... Leadership Excellence Course . In September and October ... Course to Albuquerque , Indianapolis , ... Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
(Date:8/28/2014)... Aug. 28, 2014 Nonin Medical, Inc., the ... noninvasive medical monitoring, today announced that the Food and ... OEM/eHealth finger pulse oximeter for use in ... plugs into a telemedicine hub or kiosk through a ... in pediatric to adult patients. The Model 3231 received ...
Breaking Medicine Technology:TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... 10, 2011 Key Equipment Finance , one ... an affiliate of KeyCorp (NYSE: KEY ) ... exclusive, long term, program agreement with Hitachi Medical ... U.S. distributor of Hitachi Medical Corporation,s diagnostic imaging products. ...
... Jan. 7, 2011 Questcor Pharmaceuticals, Inc. (Nasdaq: ... Annual J.P. Morgan Healthcare Conference has been rescheduled for 9:00 ... St. Francis Hotel in San Francisco. Questcor was originally scheduled ... 2011. Don M. Bailey, President and Chief Executive Officer, will ...
Cached Medicine Technology:Key Equipment Finance Enters Long-Term Program Agreement With Hitachi Medical Systems America 2Key Equipment Finance Enters Long-Term Program Agreement With Hitachi Medical Systems America 3
(Date:8/28/2014)... HORNE LLP has laid out the ... The $67 million firm has more than feel-good emotions ... in the balance. , Described by experts in the ... of Baby Boomers creating succession issues, poor leadership development ... creating culture wars within firms that are threatening the ...
(Date:8/28/2014)... third of women who are given information about the ... may not fully understand the risks involved, according to ... (BJC) , today (Friday). , In a survey of ... College London (UCL) found that 64 per cent felt ... the chance that screening will pick up cancers that ...
(Date:8/28/2014)... Worth, FL (PRWEB) August 28, 2014 ... National Recovery Month throughout September. This month will ... addiction treatment and mental health services. Along with ... Treatment Group is helping to spread the word ... began in 1989, honoring the work of treatment ...
(Date:8/28/2014)... 2014 Millennium Treatment Group has noticed ... the workplace. A recent report from the National ... that drug abuse is costing employers an estimated $81 ... addicted to drugs affect their employers and the company ... the workplace, causing expensive problems for their employers, such ...
(Date:8/28/2014)... HealthDay Reporter THURSDAY, Aug. 28, ... may worsen symptoms of multiple sclerosis (MS), a new study ... as vitamin D, smoking and Epstein Barr virus infection. Our ... factor affecting MS patients," said lead researcher Dr. Mauricio Farez, ... Aires. Multiple sclerosis is a disease of the nervous ...
Breaking Medicine News(10 mins):Health News:HORNE LLP Proclaims War on Accounting Firm Culture 2Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Drug Use Causes Problems in the Workplace 2Health News:Could Too Much Salt Harm MS Patients? 2Health News:Could Too Much Salt Harm MS Patients? 3
... Reporter , THURSDAY, March 3 (HealthDay News) -- More young ... men are engaging in same-sex encounters, according to a new ... statistics compiled from interviews with 13,500 men and women aged ... also indicates that more than half of young people under ...
... will hold its 111th General Meeting May 21-24, ... will feature approximately 3,000 individual scientific presentations spanning ... attendance of 10,000. Microbiologists study living organisms ... to human and animal health, agriculture, the environment ...
... 3 (HealthDay News) -- The brain,s so-called reward center actually ... experiences causing fear, finds a new study in mice. ... may help explain why some people are thrill-seekers. Pleasurable ... off a bridge, can trigger the production of dopamine, a ...
... HealthDay Reporter , THURSDAY, March 3 (HealthDay News) -- A new ... a position thought to pose a risk for SIDS -- have ... on their backs. The discovery suggests that a lack of ... at a higher risk of sudden infant death syndrome while sleeping: ...
... Medicine have discovered that a natural product isolated from a ... or lei gong teng, and used for hundreds of years ... gene control machinery in the cell. The report, published as ... Chemical Biology, suggests that the natural product could be ...
... Unexpected results from a Scripps Research Institute and ModGene, ... to the liver instead of the brain as the source ... with this devastating condition. The findings could offer a relatively ... was published online today in The Journal of Neuroscience ...
Cached Medicine News:Health News:More Young People Delay Sex, Try Oral Sex First, CDC Says 2Health News:More Young People Delay Sex, Try Oral Sex First, CDC Says 3Health News:American Society for Microbiology to host 111th General Meeting in New Orleans 2Health News:Research Uncovers Clue to SIDS 2Health News:Solving a traditional Chinese medicine mystery 2Health News:Solving a traditional Chinese medicine mystery 3Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 2Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 3Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 4
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
PDA application contains 15,000+ ICD-9-CM Diagnosis codes....
Contains the most common procedures from all orthopedic sub-specialties organized by body area....
Athouritative, on the spot answers for acute care and consultations....
Medicine Products: